Health Care & Life Sciences » Pharmaceuticals | Dicerna Pharmaceuticals Inc.

Dicerna Pharmaceuticals Inc.

Dicerna Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
52.97 M
Public Float
35.07 M
Dicerna Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.7
Market Cap
$1.01 B
Shares Outstanding
68.32 M
Public Float
45.19 M

Profile

Address
87 Cambridgepark Drive
Cambridge Massachusetts 02140
United States
Employees -
Website http://www.dicerna.com
Updated 07/08/2019
Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases using its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A.

Financials

View All

Douglas M. Fambrough
President, Chief Executive Officer & Director
David Michael Madden
Chairman